Membrane for use with implantable devices
First Claim
1. A biointerface membrane, the membrane comprising:
- a first domain, wherein the first domain comprises a solid portion having a plurality of interconnected cavities formed therein, wherein the solid portion comprises silicone; and
a second domain, wherein the second domain is permeable to the passage of an analyte and is impermeable to cells or cell processes.
1 Assignment
0 Petitions
Accused Products
Abstract
The present invention provides a biointerface membrane for use with an implantable device that interferes with the formation of a barrier cell layer including; a first domain distal to the implantable device wherein the first domain supports tissue attachment and interferes with barrier cell layer formation and a second domain proximal to the implantable device wherein the second domain is resistant to cellular attachment and is impermeable to cells. In addition, the present invention provides sensors including the biointerface membrane, implantable devices including these sensors or biointerface membranes, and methods of monitoring glucose levels in a host utilizing the analyte detection implantable device of the invention. Other implantable devices which include the biointerface membrane of the present invention, such as devices for cell transplantation, drug delivery devices, and electrical signal delivery or measuring devices are also provided.
1016 Citations
51 Claims
-
1. A biointerface membrane, the membrane comprising:
-
a first domain, wherein the first domain comprises a solid portion having a plurality of interconnected cavities formed therein, wherein the solid portion comprises silicone; and
a second domain, wherein the second domain is permeable to the passage of an analyte and is impermeable to cells or cell processes. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13)
-
- 14. An implantable device, the device comprising a biointerface membrane, the membrane comprising a first domain and a second domain, wherein the first domain is distal to the implantable device, wherein the first domain comprises a solid portion comprising silicone and having a plurality of interconnected cavities formed therein, wherein the second domain is proximal to the implantable device, and wherein the second domain is permeable to the passage of a chemical and is impermeable to cells or cell processes.
-
22. A method of monitoring an analyte level, the method comprising:
-
providing a host;
providing an implantable analyte sensor, the sensor comprising a biointerface membrane, the membrane comprising a first domain and a second domain, wherein the first domain is distal to the implantable device, wherein the first domain comprises a solid portion comprising silicone and having a plurality of interconnected cavities formed therein, wherein the second domain is proximal to the implantable device, and wherein the second domain is permeable to the passage of an analyte and is impermeable to cells or cell processes;
implanting the sensor in the host; and
monitoring an analyte level. - View Dependent Claims (23, 24, 25)
-
-
26. An implantable device, the device comprising:
-
a sensing region configured to permit continuous analyte sensing in vivo; and
a membrane, the membrane comprising a biointerface region comprising a cavernous first portion and a non-cavernous second portion, wherein the non-cavernous second portion is resistant to cellular attachment, cells, or cell processes, and wherein the non-cavernous second portion is permeable to the passage of at least one chemical. - View Dependent Claims (27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44)
-
-
45. An implantable glucose sensor, the sensor comprising:
-
a porous silicone portion; and
a non-porous skin, wherein the non-porous skin is adjacent to the porous silicone portion, and wherein the non-porous skin is permeable to glucose and is impermeable to cells or cell processes.
-
-
46. An implantable sensor, the sensor comprising:
-
a porous membrane comprising silicone; and
a non-porous membrane that is permeable to analytes and impermeable to cells and cell processes.
-
-
47. An implantable glucose sensor, the sensor comprising:
-
a fibrous domain that supports tissue ingrowth; and
a non-fibrous domain, wherein the non-fibrous domain is adjacent to the fibrous domain, and wherein the non-fibrous domain is permeable to analytes is impermeable to cells or cell processes.
-
-
48. An implantable sensor for implantation in soft tissue, the sensor comprising:
-
a sensing region; and
a biointerface membrane, wherein the biointerface membrane becomes ingrown with vascularized tissues upon implantation into soft tissue, and wherein the vascularized tissues facilitate transport of an analyte between the soft tissue and the sensing region.
-
-
49. An implantable glucose sensor for measuring glucose in soft tissue, wherein the sensor comprises:
a biointerface membrane, wherein host tissue integration into the biointerface membrane permits accurate sensor function.
-
50. A method for measuring an analyte in a soft tissue, the method comprising:
-
implanting an analyte sensor in a soft tissue of a host;
measuring an analyte concentration prior to tissue ingrowth;
permitting ingrowth of tissue into a portion of the sensor; and
thereafter measuring an analyte concentration.
-
-
51. A method for measuring an analyte in a soft tissue, the method comprising:
-
implanting an analyte sensor in a host;
functionally measuring an analyte concentration prior to tissue ingrowth; and
functionally measuring an analyte concentration after tissue ingrowth.
-
Specification